We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3B
AUM Growth
+$175M
(+6.2%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
32.91%
Holding
863
New
116
Increased
124
Reduced
210
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$14.6M |
| 2 |
Olin
OLN
|
+$13.5M |
| 3 |
Dick's Sporting Goods
DKS
|
+$12.1M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$9.78M |
| 5 |
Darden Restaurants
DRI
|
+$9.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$25.1M |
| 2 |
Eli Lilly
LLY
|
+$17M |
| 3 |
Procter & Gamble
PG
|
+$14.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$11.5M |
| 5 |
eBay
EBAY
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.15% |
| 2 | Consumer Discretionary | 18.06% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 9.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Collegium Pharmaceutical
COLL
$956M
| $844K | 0.03% |
35,700
| – | – |
|
327
Pinduoduo
PDD
$131B
| $841K | 0.03% |
6,618
-4,500
| -40% | -$585K |
|
328
Curis
CRIS
$7.83M
| $837K | 0.03% |
+260
| New | +$1.17M |
|
329
Oil States International
OIS
$491M
| $836K | 0.03% |
106,548
| – | – |
|
330
Sarepta Therapeutics
SRPT
$1.77B
| $832K | 0.03% |
10,700
| – | – |
|
331
Matador Resources
MTDR
$6.09B
| $829K | 0.03% |
+23,015
| New | +$671K |
|
332
Alamo Group
ALG
$2.05B
| $827K | 0.03% |
5,417
+12
| +0.2% | +$1.86K |
|
333
Horizon Bancorp
HBNC
$1.04B
| $826K | 0.03% |
47,400
| – | – |
|
334
RadNet
RDNT
$5.69B
| $825K | 0.03% |
24,500
| – | – |
|
335
Abercrombie & Fitch
ANF
$5B
| $819K | 0.03% |
+17,631
| New | +$710K |
|
336
National Beverage
FIZZ
$3.01B
| $814K | 0.03% |
17,232
+38
| +0.2% | +$1.84K |
|
337
NWPX Infrastructure Inc
NWPX
$1.15B
| $813K | 0.03% |
28,800
-29,292
| -50% | -$930K |
|
|
UBA
338
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $810K | 0.03% |
+41,800
| New | +$772K |
|
339
AdvanSix
ASIX
$444M
| $809K | 0.03% |
+27,100
| New | +$813K |
|
340
Amtech Systems
ASYS
$272M
| $805K | 0.03% |
83,469
+669
| +0.8% | +$6.86K |
|
341
Red Robin
RRGB
$152M
| $805K | 0.03% |
24,315
| – | – |
|
|
DVAX
342
DELISTED
Dynavax Technologies
DVAX
| $800K | 0.03% |
81,200
| – | – |
|
343
Mid Penn Bancorp
MPB
$952M
| $792K | 0.03% |
+28,886
| New | +$786K |
|
|
RADA
344
DELISTED
Rada Electronic Industries Ltd
RADA
| $790K | 0.03% |
64,800
| – | – |
|
345
Conduent
CNDT
$264M
| $777K | 0.03% |
103,638
-500
| -0.5% | -$3.65K |
|
346
Organogenesis Holdings
ORGO
$239M
| $776K | 0.03% |
+46,672
| New | +$870K |
|
347
Agilent Technologies
A
$41.2B
| $772K | 0.03% |
5,223
+21
| +0.4% | +$2.86K |
|
348
Avnet
AVT
$7.92B
| $772K | 0.03% |
19,256
| – | – |
|
349
Aldeyra Therapeutics
ALDX
$93.5M
| $767K | 0.03% |
+67,700
| New | +$814K |
|
350
Acadia Healthcare
ACHC
$2.94B
| $765K | 0.03% |
12,206
| – | – |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, ClariVest Asset Management held 863 positions worth $3B, up 6.2% from $2.83B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
ClariVest Asset Management withdrew a net $110M in Q2 2021, closing 111 positions and reducing 210 holdings. Its most notable exit was Amgen, an estimated $25.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, ClariVest Asset Management opened a new position in Charles Schwab worth $15M.
- ClariVest Asset Management's largest Q2 2021 buy was Charles Schwab: 206,235 shares worth $15M.
- ClariVest Asset Management added most to Olin in Q2 2021, an estimated $13.5M increase.
- ClariVest Asset Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $17M.
- ClariVest Asset Management fully exited Amgen in Q2 2021, selling an estimated $25.1M.
- ClariVest Asset Management's ten largest holdings make up 33% of its $3B portfolio in Q2 2021.
- ClariVest Asset Management opened 116 new positions and closed 111 in Q2 2021.
- ClariVest Asset Management's portfolio value rose 6.2% quarter-over-quarter to $3B.
Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.